[Metabolic profile of hypertensive patients Treated In The Cardiology Department Of The University Teaching Hospital Le Luxembourg].

Le Mali medical Pub Date : 2024-01-01

Coumba Thiam, Mamadou Touré, Asmaou Kéita, Oumar Koné, Daouda Fofana, Boubacar Sonfo, Youssouf Camara, Illo Bella Diall, Souleymane Coulibaly, Ichaka Menta

{"title":"[Metabolic profile of hypertensive patients Treated In The Cardiology Department Of The University Teaching Hospital Le Luxembourg].","authors":"Coumba Thiam, Mamadou Touré, Asmaou Kéita, Oumar Koné, Daouda Fofana, Boubacar Sonfo, Youssouf Camara, Illo Bella Diall, Souleymane Coulibaly, Ichaka Menta","doi":"","DOIUrl":null,"url":null,"abstract":"Objective: To assess the profile of metabolic syndrome (MS) in a hypertensive population in Mali.Patients and methods: Prospective study from June 1, 2022 to June 31, 2022, in the cardiology department of the Mother-Child University Hospital in Bamako, Luxembourg. Our study sample consisted of adult hypertensive patients, aged 18 years and older, received as an outpatient. Patients were included in our study after informed consent. The SM was established based on International Diabetes Federation (IDF) definitions.Results: Out of 520 patients, 238 were included in our study. The prevalence of SM was 30.2% according to IDF criteria. There was a female predominance (66%). The mean age was 57 ± 5 years. Grade II hypertension was in the majority with 39%. Seventy-five percent of patients with metabolic syndrome had 3 risk factors. Ischemic stroke was the most common complication with a rate of 12%. Dual therapy was indicated in 59.23% of patients. Calcium channel blockers were the most prescribed with a rate of 74.5%. SM is a reality in Mali. Adequate preventive measures are necessary to limit its progression.","PeriodicalId":74061,"journal":{"name":"Le Mali medical","volume":"39 1","pages":"17-22"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Le Mali medical","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To assess the profile of metabolic syndrome (MS) in a hypertensive population in Mali.

Patients and methods: Prospective study from June 1, 2022 to June 31, 2022, in the cardiology department of the Mother-Child University Hospital in Bamako, Luxembourg. Our study sample consisted of adult hypertensive patients, aged 18 years and older, received as an outpatient. Patients were included in our study after informed consent. The SM was established based on International Diabetes Federation (IDF) definitions.

Results: Out of 520 patients, 238 were included in our study. The prevalence of SM was 30.2% according to IDF criteria. There was a female predominance (66%). The mean age was 57 ± 5 years. Grade II hypertension was in the majority with 39%. Seventy-five percent of patients with metabolic syndrome had 3 risk factors. Ischemic stroke was the most common complication with a rate of 12%. Dual therapy was indicated in 59.23% of patients. Calcium channel blockers were the most prescribed with a rate of 74.5%. SM is a reality in Mali. Adequate preventive measures are necessary to limit its progression.

本刊更多论文

[卢森堡大学教学医院心脏病科治疗的高血压患者的代谢概况]。

目的：评估马里高血压人群的代谢综合征（MS）概况：评估马里高血压人群的代谢综合征（MS）概况：2022年6月1日至2022年6月31日在卢森堡巴马科母婴大学医院心脏病科进行的前瞻性研究。研究样本包括门诊接诊的 18 岁及以上成年高血压患者。患者在知情同意后被纳入我们的研究。SM是根据国际糖尿病联盟（IDF）的定义确定的：在 520 名患者中，238 人被纳入研究。根据 IDF 标准，SM 患病率为 30.2%。女性占多数（66%）。平均年龄为 57 ± 5 岁。二级高血压患者占多数，为 39%。75%的代谢综合征患者有三个风险因素。缺血性中风是最常见的并发症，发生率为 12%。59.23%的患者需要接受双重治疗。钙通道阻滞剂是最常用的处方药，使用率为 74.5%。SM 在马里已成为现实。有必要采取适当的预防措施来限制其发展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Le Mali medical

CiteScore

0.10

自引率

0.00%

发文量